Pressemitteilungen

Pulsenmore (TASE: PULS), a pioneering provider of home-based ultrasound technology, has announced the renewal and expansion of its strategic partnership with Clalit Health Services, Israel’s largest HMO. Over the next five years, Pulsenmore will supply 25,000 units of its advanced home ultrasound devices to support Clalit’s commitment to accessible, high-quality prenatal care.

Pulsenmore secured a commercial agreement with Sheba Medical Center, Tel Hashomer for remote patient monitoring of highrisk pregnancies using its’ home ultrasound solution. Sheba Medical Center, will utilize Pulsenmore’s solution as part of its’ obstetrics department in the ‘Sheba Beyond virtual hospital, offering top-quality medical services to insured individuals across various health funds. Full article belowThe feature highlighted his achievements, showcasing his leadership and our collective efforts to make Pulsenmore a healthcare trailblazer.

Pulsenmore (TASE:PULS), the world leader in self-scan ultrasound technology for at-home use and remote clinical diagnosis, announces its new clinical study collaboration with Michigan Medicine. The study will examine the ability to conduct a remote biophysical profile (BPP) test, by using the Pulsenmore home ultrasound with the guidance of a remote clinician, potentially reducing the clinical burden.

Pulsenmore’s CEO, Dr. Elazar Sonnenschein, has been named “Man of the Year” by Yedioth Ahronoth, the most renowned daily publication in Israel.
The feature highlighted his achievements, showcasing his leadership and our collective efforts to make Pulsenmore a healthcare trailblazer.

RAMAT GAN, Israel, Jan. 10, 2024 /PRNewswire/ — Pulsenmore (TASE: PULS), the global leader in self-scan ultrasound technology for home use, proudly announces the approval of its pioneering prenatal care solution by the Brazilian Health Regulatory Agency (ANVISA), marking a significant milestone in the company’s international expansion.

RAMAT GAN, Israel, Jan. 10, 2024 /PRNewswire/ — Pulsenmore (TASE: PULS), the global leader in self-scan ultrasound technology for home use, proudly announces the approval of its pioneering prenatal care solution by the Brazilian Health Regulatory Agency (ANVISA), marking a significant milestone in the company’s international expansion. This endorsement positions Pulsenmore at the forefront of innovative healthcare, unlocking possibilities for

A new handheld, self-scanning ultrasound device that attaches to a smartphone allows pregnant women to see their baby in the womb at any time and in the comfort of their own home, without a visit to a hospital or clinic.

Discover Israel’s thriving innovation ecosystem and the latest technologies on the horizon in this special edition as is takes a deep dive into Israel’s remarkable 75-year history of innovation, highlighting the country’s key contributions to science and technology. One of the featured technologies is Pulsenmore, a remote ultrasound device that’s revolutionizing at-home maternal fetal monitoring.